Gastric Adenocarcinoma? Looks Similar but Behaves Differently!
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
A 63-year-old male presented with unintentional weight loss of 20 lb over a 4-month duration. He reported loss of appetite, intermittent post-prandial nausea, bloating, and early satiety. The patient also complained of dyspepsia and had been empirically treated for reflux disease during the previous 2 years. He denied vomiting, dysphagia, odynophagia, or abdominal pain. There was no history of overt gastrointestinal bleeding or alterations in bowel habits. Additionally, he denied fevers, night sweats, cough, or dyspnea. He had quit smoking 25 years ago, and denied alcohol use. His past medical history was significant for basal cell carcinoma treated with local curative therapy and he was without recurrence on surveillance. Pertinent family history included a paternal uncle with lung cancer at the age of 74. Physical examination was unremarkable except for occult heme-positive stools. Laboratory evaluation revealed elevated liver enzymes (ALT—112 U/L, reference range, 7
- Jang KY, Moon WS, Lee H, Kim CY, Park HS. Gastric collision tumor of large cell neuroendocrine carcinoma and adenocarcinoma—a case report. Pathol Res Pract. 2010;206:387–90. CrossRef
- Capella C, Solcia E, Sobin LH, Arnold R. Endocrine tumours of the stomach. In: Hamilton SR, Aaltonen LA, editors. World health organization classification of tumours of the digestive system. Lyon: IARC; 2000.
- Solcia EKG, Sobin LH. Histological typing of endocrine tumors. World health organization international histological classification of tumors. 2nd ed. New York: Springer; 2000.
- Capella C, Heitz PU, Hofler H, Solcia E, Kloppel G. Revised classification of neuroendocrine tumors of the lung, pancreas and gut. Digestion. 1994;55 Suppl 3:11–23. CrossRef
- Rindi G, Luinetti O, Cornaggia M, Capella C, Solcia E. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology. 1993;104:994–1006.
- Rindi G. Clinicopathologic aspects of gastric neuroendocrine tumors. Am J Surg Pathol. 1995;19 Suppl 1:S20–9.
- Rindi G, Bordi C, Rappel S, La Rosa S, Stolte M, Solcia E. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior. World J Surg. 1996;20:168–72. CrossRef
- Rindi G, Azzoni C, La Rosa S, et al. ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis. Gastroenterology. 1999;116:532–42. CrossRef
- Matsui K, Jin XM, Kitagawa M, Miwa A. Clinicopathologic features of neuroendocrine carcinomas of the stomach: appraisal of small cell and large cell variants. Arch Pathol Lab Med. 1998;122:1010–7.
- Matsui K, Kitagawa M, Miwa A, Kuroda Y, Tsuji M. Small cell carcinoma of the stomach: a clinicopathologic study of 17 cases. Am J Gastroenterol. 1991;86:1167–75.
- Jiang SX, Mikami T, Umezawa A, Saegusa M, Kameya T, Okayasu I. Gastric large cell neuroendocrine carcinomas: a distinct clinicopathologic entity. Am J Surg Pathol. 2006;30:945–53. CrossRef
- Moertel CG, Kvols LK, O’Connell MJ, Rubin J. Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms. Cancer. 1991;68:227–32. CrossRef
- Kirii Y, Ichikawa C, Miyamoto M, et al. A case of gastric large cell neuroendocrine carcinoma (LCNEC) for whom chemotherapy of CDDP+CPT-11 proved very effective. Gan To Kagaku Ryoho. 2010;37:895–8.
- Gastric Adenocarcinoma? Looks Similar but Behaves Differently!
Journal of Gastrointestinal Cancer
Volume 43, Issue 1 , pp 133-136
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Department of Internal Medicine, University of Connecticut, 263 Farmington Avenue, Farmington, CT, 06032, USA
- 2. Division of Hematology-Oncology, Department of Internal Medicine, Hartford Hospital, Hartford, CT, USA